TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Operating Income

Annual figures by fiscal year, from SEC filings.

2012: -$9.57M2013: -$156.28M2014: -$232.54M2015: -$181.90M2016: -$180.47M2017: -$260.12M2018: -$238.75M2019: -$251.91M2020: -$297.63M2021: -$257.78M2022: -$91.96M2023: -$56.03M2024: -$46.95M2025: -$3.60M-$3.60M
2012Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$3.60M+92.3%
2024-$46.95M+16.2%
2023-$56.03M+39.1%
2022-$91.96M+64.3%
2021-$257.78M+13.4%
2020-$297.63M-18.1%
2019-$251.91M-5.5%
2018-$238.75M+8.2%
2017-$260.12M-44.1%
2016-$180.47M+0.8%
2015-$181.90M+21.8%
2014-$232.54M-48.8%
2013-$156.28M-1532.2%
2012-$9.57M—